Nomura, Hisashi <br/><br/>
Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapy.  [electronic resource] 

 -  The Journal of dermatology  Jul 2017 
 - 818-821 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1346-8138 
<br/><br/><label>Standard No.: </label>10.1111/1346-8138.13810  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antineoplastic Agents, Immunological--therapeutic use<br/>Biopsy<br/>CTLA-4 Antigen--antagonists & inhibitors<br/>Chemotherapy, Adjuvant--adverse effects<br/>Drug Eruptions--diagnosis<br/>Drug Resistance<br/>Erythema Multiforme--chemically induced<br/>Fever--chemically induced<br/>Glucocorticoids--pharmacology<br/>Humans<br/>Indoles--therapeutic use<br/>Ipilimumab<br/>Lung Diseases, Interstitial--drug therapy<br/>Lymphatic Metastasis<br/>Male<br/>Melanoma--genetics<br/>Mutation<br/>Neoplasm Recurrence, Local--pathology<br/>Nivolumab<br/>Parotid Neoplasms--drug therapy<br/>Programmed Cell Death 1 Receptor--antagonists & inhibitors<br/>Proto-Oncogene Proteins B-raf--antagonists & inhibitors<br/>Pulse Therapy, Drug<br/>Skin Neoplasms--genetics<br/>Sulfonamides--therapeutic use<br/>Tomography, X-Ray Computed<br/>Trimethoprim, Sulfamethoxazole Drug Combination--therapeutic use<br/>Vemurafenib<br/>Withholding Treatment